HOME > Investors > Press Releases
2009-03-06
ViroMed Receives Approval for Diabetic Neuropathy Phase I/II Trial
2009-03-04
ViroMed Receives Approval from US FDA for Phase I/II Trial for Diabetic Neuropathy
2008-12-03
[Pharmaceutical Business Review] ViroMed launches joint study with Biologics Delivery Systems
2008-12-03
[redOrbit] ViroMed Launches Joint Study With Biologics Delivery Systems
2008-11-18
[Allina] Minneapolis Heart Institute Foundation researcher goes to Korea to present ViroMed study results
11 12 13 14 15 16 17 18 19